Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
abbvie
3
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
3
×
biotech
boston blog main
boston top stories
eli lilly
fda
merck
national
new york top stories
4d molecular therapeutics
acne
acorda therapeutics
agenus
allergan
amgen
ampyra
apokyn
apomorphine
astrazeneca
auris health
avexis
bayer
biohaven
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
centers for medicare and medicaid services
What
approved
fda
treatment
3
×
disease
drug
new
nod
acorda
adults
allergan
bio
class
companies
cope
digital
epidemic
episodes
fatty
frenzied
friday
gets
growing
help
known
late
led
liver
looms
meant
medications
medicines
merck
migraine
monday
nash
news
parkinson’s
patients
pill
race
Language
unset
Current search:
abbvie
×
treatment
×
photo
×
" new york blog main "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms